Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte precursor cell | 14 studies | 57% ± 18% | |
microglial cell | 6 studies | 22% ± 5% | |
astrocyte | 6 studies | 24% ± 6% | |
glutamatergic neuron | 5 studies | 43% ± 23% | |
endothelial cell | 4 studies | 29% ± 8% | |
GABAergic neuron | 4 studies | 43% ± 18% | |
macrophage | 4 studies | 24% ± 5% | |
oligodendrocyte | 4 studies | 19% ± 3% | |
differentiation-committed oligodendrocyte precursor | 3 studies | 49% ± 8% | |
interneuron | 3 studies | 36% ± 22% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 7 studies | 31% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 6517.43 | 1445 / 1445 | 100% | 27.94 | 183 / 183 |
brain | 100% | 16488.98 | 2641 / 2642 | 100% | 93.06 | 702 / 705 |
prostate | 100% | 9286.56 | 245 / 245 | 99% | 27.28 | 499 / 502 |
uterus | 100% | 6246.20 | 170 / 170 | 99% | 23.65 | 456 / 459 |
breast | 99% | 6447.72 | 456 / 459 | 98% | 23.18 | 1100 / 1118 |
bladder | 100% | 7304.33 | 21 / 21 | 97% | 23.90 | 491 / 504 |
intestine | 99% | 5915.61 | 952 / 966 | 97% | 16.96 | 513 / 527 |
lung | 99% | 5860.03 | 571 / 578 | 95% | 20.16 | 1094 / 1155 |
thymus | 98% | 4637.25 | 638 / 653 | 95% | 14.09 | 574 / 605 |
ovary | 100% | 4597.10 | 180 / 180 | 91% | 14.78 | 393 / 430 |
stomach | 96% | 3635.48 | 343 / 359 | 95% | 15.05 | 272 / 286 |
skin | 91% | 6898.02 | 1640 / 1809 | 98% | 17.44 | 464 / 472 |
pancreas | 86% | 2488.94 | 283 / 328 | 98% | 26.49 | 174 / 178 |
adrenal gland | 90% | 2692.99 | 233 / 258 | 83% | 14.26 | 190 / 230 |
kidney | 91% | 3217.80 | 81 / 89 | 77% | 8.31 | 690 / 901 |
liver | 95% | 3428.03 | 214 / 226 | 70% | 6.87 | 286 / 406 |
eye | 0% | 0 | 0 / 0 | 100% | 15.48 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 23.87 | 29 / 29 |
spleen | 100% | 9702.41 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 21.58 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 39.54 | 1 / 1 |
muscle | 100% | 11013.60 | 802 / 803 | 0% | 0 | 0 / 0 |
adipose | 100% | 4631.52 | 1198 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 5358.18 | 1323 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 6914.35 | 914 / 929 | 0% | 0 | 0 / 0 |
heart | 81% | 4021.48 | 701 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006897 | Biological process | endocytosis |
GO_2000369 | Biological process | regulation of clathrin-dependent endocytosis |
GO_0050731 | Biological process | positive regulation of peptidyl-tyrosine phosphorylation |
GO_0007264 | Biological process | small GTPase-mediated signal transduction |
GO_0016310 | Biological process | phosphorylation |
GO_0006468 | Biological process | protein phosphorylation |
GO_0007166 | Biological process | cell surface receptor signaling pathway |
GO_0005886 | Cellular component | plasma membrane |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0016020 | Cellular component | membrane |
GO_0030136 | Cellular component | clathrin-coated vesicle |
GO_0070436 | Cellular component | Grb2-EGFR complex |
GO_0005829 | Cellular component | cytosol |
GO_0005912 | Cellular component | adherens junction |
GO_0005737 | Cellular component | cytoplasm |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005905 | Cellular component | clathrin-coated pit |
GO_0097268 | Cellular component | cytoophidium |
GO_0005768 | Cellular component | endosome |
GO_0030659 | Cellular component | cytoplasmic vesicle membrane |
GO_0005634 | Cellular component | nucleus |
GO_0004715 | Molecular function | non-membrane spanning protein tyrosine kinase activity |
GO_0004712 | Molecular function | protein serine/threonine/tyrosine kinase activity |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0005095 | Molecular function | GTPase inhibitor activity |
GO_0004713 | Molecular function | protein tyrosine kinase activity |
GO_0005154 | Molecular function | epidermal growth factor receptor binding |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0050699 | Molecular function | WW domain binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
Gene name | TNK2 |
Protein name | Activated CDC42 kinase 1 (ACK-1) (EC 2.7.10.2) (EC 2.7.11.1) (Tyrosine kinase non-receptor protein 2) non-specific protein-tyrosine kinase (EC 2.7.10.2) Tyrosine kinase non receptor 2 |
Synonyms | ACK1 hCG_2004203 |
Description | FUNCTION: Non-receptor tyrosine-protein and serine/threonine-protein kinase that is implicated in cell spreading and migration, cell survival, cell growth and proliferation. Transduces extracellular signals to cytosolic and nuclear effectors. Phosphorylates AKT1, AR, MCF2, WASL and WWOX. Implicated in trafficking and clathrin-mediated endocytosis through binding to epidermal growth factor receptor (EGFR) and clathrin. Binds to both poly- and mono-ubiquitin and regulates ligand-induced degradation of EGFR, thereby contributing to the accumulation of EGFR at the limiting membrane of early endosomes. Downstream effector of CDC42 which mediates CDC42-dependent cell migration via phosphorylation of BCAR1. May be involved both in adult synaptic function and plasticity and in brain development. Activates AKT1 by phosphorylating it on 'Tyr-176'. Phosphorylates AR on 'Tyr-267' and 'Tyr-363' thereby promoting its recruitment to androgen-responsive enhancers (AREs). Phosphorylates WWOX on 'Tyr-287'. Phosphorylates MCF2, thereby enhancing its activity as a guanine nucleotide exchange factor (GEF) toward Rho family proteins. Contributes to the control of AXL receptor levels. Confers metastatic properties on cancer cells and promotes tumor growth by negatively regulating tumor suppressor such as WWOX and positively regulating pro-survival factors such as AKT1 and AR. Phosphorylates WASP . . |
Accessions | ENST00000673420.1 ENST00000381916.7 A0A5F9ZGY5 ENST00000671734.1 A0A5F9ZGX5 ENST00000672024.1 A0A5F9ZI29 A0A5F9ZHX6 ENST00000672098.1 ENST00000673038.1 ENST00000333602.14 [Q07912-1] ENST00000672887.2 ENST00000673374.1 A0A5F9ZHQ1 C9J1X3 ENST00000672548.1 A0A5F9ZHP9 ENST00000671767.1 ENST00000428187.7 ENST00000673559.1 ENST00000672145.1 A0A5F9ZHB0 ENST00000673443.1 A0A5F9ZH66 ENST00000672542.1 A0A5F9ZHI7 A0A5F9ZHJ2 A0A499FJ16 A0A5F9ZHP4 ENST00000671753.1 [Q07912-3] A0A5F9ZHC7 A0A5F9ZI44 ENST00000672669.1 ENST00000678220.1 ENST00000671880.1 A0A5F9ZHL4 ENST00000439230.6 [Q07912-2] ENST00000672886.1 Q07912 A0A5F9ZHD0 A0A5F9ZHK8 ENST00000672623.1 A0A5F9ZH01 |